WeConnectPatients.com · Kidney & Immune Health

Your immune system is working against you. Here’s what that means — and what you can do about it.

Inflammatory bowel disease isn’t a stomach bug. It’s a chronic immune disease that attacks your digestive tract. Whether it’s Crohn’s disease or ulcerative colitis, here’s what you need to know.

Americans

Living with Crohn’s disease or ulcerative colitis

Peak Age

Most people are first diagnosed between their twenties and thirties, with a second peak in people over 50

Depression or Anxiety

Estimated prevalence of clinical depression or anxiety disorders among people with IBD

Work Impact

Nearly half report IBD-related disruption to work or daily activities — including lost hours, reduced productivity, and missed opportunities

Your immune system is attacking your digestive tract. That’s what IBD is.

Inflammatory bowel disease isn’t something you ate. It isn’t stress (though stress doesn’t help). And it’s not something you can push through with willpower. Your immune system has turned on your own gut, and the damage is real.

IBD is an umbrella term for two main conditions: Crohn’s disease and ulcerative colitis. They’re related but different. Ulcerative colitis inflames the lining of your colon and rectum in a continuous pattern. Crohn’s can show up anywhere along your digestive tract, and the inflammation goes deeper into the intestinal wall.

Together, they affect more than 2.5 million Americans. Most people get diagnosed in their twenties or thirties, but it can start at any age. There’s a second peak in people over 50.

What makes IBD challenging isn’t just the physical symptoms — it’s the unpredictability. Flares can disrupt your day, your work, and your relationships in ways that are hard to explain to people who haven’t experienced it.

The mental and emotional side of IBD — anxiety, bathroom urgency, and the quiet weight of uncertainty — is real, underrecognized, and just as important as what shows up in a lab result. You deserve care that addresses all of it.

What drives IBD

IBD isn’t caused by one thing. It’s a collision of genetics, immune dysfunction, and environment.

Your immune system

In IBD, your immune system mistakenly attacks the healthy tissue lining your digestive tract. This creates chronic inflammation that damages the intestinal wall. In UC (ulcerative colitis), it’s limited to the colon. In Crohn’s, it can happen anywhere in the GI tract and goes deeper into the tissue.

Genetics

More than 200 genetic variants have been linked to IBD. If a first-degree relative has it, your risk goes up significantly. But genetics alone don’t cause it. Something in your environment has to activate the disease.

Your gut microbiome

The trillions of bacteria in your gut play a major role. In people with IBD, the balance of these organisms is disrupted. Scientists are still figuring out whether this is a cause or an effect, but it’s clearly part of the equation.

Environmental triggers

Smoking increases risk for Crohn’s disease and is associated with a more severe disease course. For ulcerative colitis, the relationship is paradoxical — smoking appears to have a modest protective effect, though the mechanisms are not fully understood. Regardless of IBD type, smoking cessation is recommended due to its broader health risks. Antibiotic use, diet, stress, and living in a Westernized or industrialized environment are all associated with higher rates. Rates are rising fastest in countries adopting Western lifestyles.

Rising incidence in every community

IBD was once thought of as a disease primarily affecting white populations. That’s changed. Incidence is rising across all racial and ethnic groups. African American, Hispanic, and Asian communities are seeing increases, often with later diagnosis and more severe disease at presentation.

How IBD is diagnosed

Getting diagnosed can take months or years. Knowing what to expect helps.

Symptoms that don’t quit

Persistent diarrhea (often bloody), abdominal pain, urgency, weight loss, and fatigue lasting more than a few weeks. These aren’t just stomach issues. They’re signals something deeper is happening.

Blood and stool tests

Your doctor checks inflammation markers (CRP, fecal calprotectin), blood counts, and nutritional markers. Fecal calprotectin — a protein found in stool that signals gut inflammation — is especially useful and can help track disease activity over time.

Colonoscopy

The gold standard. A camera examines your colon and small intestine, and tissue samples are taken. This is how doctors distinguish UC from Crohn’s and assess how much of your GI tract is affected.

Imaging

CT or MRI enterography reveals inflammation, strictures, or fistulas in areas a colonoscopy can’t reach. Intestinal ultrasound is an emerging, non-invasive option gaining traction.

The full picture

A good diagnosis doesn’t stop at the gut. Your doctor should also assess joint pain, skin changes, eye symptoms, mental health, and nutritional status. IBD affects more than your digestive system.

Treatment has transformed

The goal isn’t just managing symptoms anymore. It’s healing the inflammation itself.

Starting Point

Anti-Inflammatory Medications

Anti-inflammatory medications called aminosalicylates (like mesalamine) are often the first step for mild UC (ulcerative colitis). They work directly on the colon lining. For Crohn’s, they’re less effective, and doctors often move to stronger options sooner.

Flare Management

Corticosteroids

Steroids like prednisone knock down a flare fast, but they’re not meant for long-term use. Side effects stack up. The goal is always to get off steroids and onto something sustainable.

Moderate to Severe

Biologics and Targeted Therapies

For many people with moderate to severe IBD, these therapies have significantly expanded the range of effective treatment options. Biologics target specific immune molecules driving the inflammation. Options include anti-TNF agents, gut-selective integrin inhibitors, IL-12/23 and IL-23 inhibitors, and oral JAK inhibitors (a type of targeted immune-signaling blocker). Many people achieve deep remission and real quality-of-life improvements.

Emerging Science

What’s Being Studied Now

Next-generation biologics, more selective oral therapies, microbiome-based treatments, and combination approaches. Clinical trials are how these options move from labs to patients.

All treatments carry potential side effects. The right treatment depends on your type of IBD, disease severity, and personal circumstances. Talk to your gastroenterologist about the risks and benefits that apply to you.

“I spent years thinking ‘manageable’ was the best I could hope for. Then I found a treatment that actually gave me my life back.”

Reflects common patient experiences

If cost or access is a barrier, ask about patient assistance programs. Many pharmaceutical companies offer support, and some clinical trials provide medications at no cost. If specialist access is limited in your area, ask your primary care provider about telehealth gastroenterology options.

Answers to common questions

Living with IBD raises real, practical questions. Here are honest answers to some of the most common ones.

What’s the difference between Crohn’s disease and ulcerative colitis?

Both are types of IBD, but they behave differently. UC affects only the colon and rectum, with continuous inflammation in the inner lining. Crohn’s can affect any part of the digestive tract, causes patchy inflammation, and goes deeper into the intestinal wall. Crohn’s can also cause complications like strictures and fistulas that UC generally doesn’t. Treatment overlaps but isn’t identical.

Will I need surgery?

Maybe. For UC, surgery (removing the colon) is technically curative, and about 10–15% of people eventually need it. For Crohn’s, surgery is needed by a significant proportion of people at some point — historical estimates suggest 40–50%, though rates have declined with newer therapies. Surgery is not curative for Crohn’s since inflammation can recur in a different part of the GI tract. Modern treatments are reducing surgery rates. Having the conversation with your doctor early — not just when things get bad — is important.

Does IBD affect mental health?

Yes. And it’s not just “feeling down about being sick.” Published research suggests that up to 30–40% of people with IBD experience clinical depression or anxiety disorders at some point (individual experiences vary widely). The brain-gut connection is real. Inflammation itself can affect your mood. If your GI doctor isn’t asking about your mental health, bring it up. It’s as important as your colonoscopy results.

Can I have children with IBD?

Yes. Most people with IBD can have healthy pregnancies. The key is getting your disease under control before conceiving. Most IBD medications are safe during pregnancy — active inflammation is actually the bigger risk. Plan with your gastroenterologist and your OB/GYN or relevant reproductive health provider. Don’t stop your medication without talking to your doctor first.

Does diet cause IBD?

No. Diet doesn’t cause IBD. But certain foods can trigger symptoms during flares. There’s no single “IBD diet” that works for everyone. Keeping a food journal helps identify your personal triggers. A registered dietitian who understands IBD can be incredibly helpful. Nutritional deficiencies are common, so monitoring matters.

How do I manage the bathroom anxiety?

This is one of the hardest parts, and nobody talks about it enough. Know your routes and your restrooms. Some people carry a restroom access card. Pelvic floor physical therapy can help with urgency. And talk to your doctor — if urgency is controlling your life, your treatment may need adjusting. IBD can also cause fatigue and difficulty concentrating during flares or while adjusting to new treatments. If these are affecting your daily life, bring them up with your care team — they’re recognized parts of the disease experience and deserve attention alongside your GI symptoms.

Is IBD the same as irritable bowel syndrome (IBS)?

No. They sound similar, but they’re fundamentally different. IBS is a functional disorder — uncomfortable but not damaging. IBD involves actual tissue damage from inflammation. You can have both, which complicates things. If you’ve been told you have IBS but your symptoms include bleeding, weight loss, or severe fatigue, push for further evaluation.

Are there communities and resources I can connect with?

The Crohn’s & Colitis Foundation is the best starting point — for both patients and caregivers. They offer support groups, educational resources, and a help line. Online communities on Reddit, Facebook, and dedicated IBD platforms connect you with people who understand what you’re going through. If you support someone with IBD, many of these communities also have spaces for caregivers and family members. You don’t have to navigate this alone.

Research & Progress

The science is transforming

IBD research is in the middle of a transformation. Scientists now understand the specific immune pathways that drive Crohn’s and UC at a molecular level, and that knowledge is producing treatments that didn’t exist even five years ago.

What’s in the pipeline: more selective oral therapies that could replace injections for some patients. Next-generation biologics targeting new immune pathways. Microbiome-based approaches, including fecal microbiota transplantation. And combination strategies that hit the disease from multiple angles at once.

As of early 2026, clinical trials are how these treatments move from research to reality. Participating gives you access to specialized care teams, emerging therapies, and close monitoring. There’s no obligation — your standard care continues either way. It’s your choice, and it’s one worth understanding.

You deserve treatment that gets IBD symptoms to remission. Not just fewer bad days.

Research into inflammatory bowel disease is moving faster than ever. Whether you have Crohn’s, UC, or aren’t sure yet, there may be options worth exploring.

Not sure where to start?

Walking into a gastroenterology appointment with the right questions changes everything. We put together a quick guide.

This content is for educational purposes only and isn’t a substitute for medical advice. Talk to your healthcare provider before making decisions about your care. Information about clinical trials is for general awareness, not an endorsement of any specific study.

Sources: Crohn’s & Colitis Foundation, AGA, ACG, NIH/NIDDK, Mayo Clinic, Lancet, Gastroenterology, peer-reviewed literature (2015–2025), ClinicalTrials.gov.

WeConnect is a Takeda initiative connecting people to clinical trial opportunities. Visit WeConnectPatients.com.